Kevin G. Liu

724 total citations
21 papers, 603 citations indexed

About

Kevin G. Liu is a scholar working on Organic Chemistry, Molecular Biology and Pharmacology. According to data from OpenAlex, Kevin G. Liu has authored 21 papers receiving a total of 603 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Organic Chemistry, 13 papers in Molecular Biology and 6 papers in Pharmacology. Recurrent topics in Kevin G. Liu's work include Catalytic C–H Functionalization Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Chemical synthesis and alkaloids (4 papers). Kevin G. Liu is often cited by papers focused on Catalytic C–H Functionalization Methods (4 papers), Cholinesterase and Neurodegenerative Diseases (4 papers) and Chemical synthesis and alkaloids (4 papers). Kevin G. Liu collaborates with scholars based in United States, Canada and Denmark. Kevin G. Liu's co-authors include Albert J. Robichaud, Thomas A. Comery, Lee E. Schechter, James F. Mattes, Deborah L. Smith, Dianne Kowal, Yanxuan Cai, Li Di, Edward H. Kerns and Millard H. Lambert and has published in prestigious journals such as Nucleic Acids Research, Journal of Medicinal Chemistry and Tetrahedron.

In The Last Decade

Kevin G. Liu

21 papers receiving 582 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kevin G. Liu United States 16 399 281 87 70 42 21 603
M. E. Layton United States 11 428 1.1× 264 0.9× 92 1.1× 79 1.1× 22 0.5× 20 647
Gisella Terre’Blanche South Africa 15 278 0.7× 210 0.7× 80 0.9× 93 1.3× 49 1.2× 47 573
Ivan Efremov United States 14 350 0.9× 267 1.0× 79 0.9× 96 1.4× 66 1.6× 26 577
Mark A. Sanner United States 13 446 1.1× 217 0.8× 118 1.4× 78 1.1× 46 1.1× 21 758
Grant Wishart United Kingdom 13 218 0.5× 397 1.4× 103 1.2× 80 1.1× 99 2.4× 29 633
E. FERNANDEZ‐ALVAREZ Spain 18 566 1.4× 205 0.7× 78 0.9× 110 1.6× 46 1.1× 52 786
Suzanne R. Kesten United States 11 468 1.2× 286 1.0× 140 1.6× 198 2.8× 24 0.6× 16 771
David J. Madar United States 13 427 1.1× 255 0.9× 33 0.4× 70 1.0× 26 0.6× 20 639
Laura Iturrino Belgium 16 268 0.7× 294 1.0× 161 1.9× 89 1.3× 56 1.3× 23 577
Paul J. Dransfield United States 12 244 0.6× 331 1.2× 75 0.9× 34 0.5× 17 0.4× 13 573

Countries citing papers authored by Kevin G. Liu

Since Specialization
Citations

This map shows the geographic impact of Kevin G. Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kevin G. Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kevin G. Liu more than expected).

Fields of papers citing papers by Kevin G. Liu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kevin G. Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kevin G. Liu. The network helps show where Kevin G. Liu may publish in the future.

Co-authorship network of co-authors of Kevin G. Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Kevin G. Liu. A scholar is included among the top collaborators of Kevin G. Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kevin G. Liu. Kevin G. Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liu, Kevin G., et al.. (2025). The Effects of GLP-1 Agonists on Musculoskeletal Health and Orthopedic Care. Current Reviews in Musculoskeletal Medicine. 18(10). 469–480. 7 indexed citations
2.
Ton, Andy, Kevin G. Liu, John C. Liu, et al.. (2024). Top 25 Most Cited Articles on Intraoperative Computer Tomography-Guided Navigation in Spine Surgery. World Neurosurgery. 184. 322–330.e1. 1 indexed citations
3.
Singh, Jaideep, et al.. (2023). A DNA unwinding equilibrium serves as a checkpoint for CRISPR-Cas12a target discrimination. Nucleic Acids Research. 51(16). 8730–8743. 9 indexed citations
4.
Liu, Kevin G., Sang‐Phyo Hong, Michelle A. Uberti, et al.. (2012). 4-(1-Phenyl-1H-pyrazol-4-yl)quinolines as novel, selective and brain penetrant metabotropic glutamate receptor 4 positive allosteric modulators. Bioorganic & Medicinal Chemistry Letters. 22(9). 3235–3239. 18 indexed citations
5.
Liu, Kevin G. & Albert J. Robichaud. (2010). 5-HT6 Medicinal Chemistry. International review of neurobiology. 94. 1–34. 27 indexed citations
6.
Liu, Kevin G., Albert J. Robichaud, James F. Mattes, et al.. (2010). Identification of 3-sulfonylindazole derivatives as potent and selective 5-HT6 antagonists. Bioorganic & Medicinal Chemistry. 19(1). 650–662. 19 indexed citations
7.
Liu, Kevin G., Albert J. Robichaud, Ronald C. Bernotas, et al.. (2010). 5-Piperazinyl-3-sulfonylindazoles as Potent and Selective 5-Hydroxytryptamine-6 Antagonists. Journal of Medicinal Chemistry. 53(21). 7639–7646. 59 indexed citations
8.
Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2009). Identification of a series of benzoxazoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 19(4). 1115–1117. 51 indexed citations
9.
Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2009). Identification of a novel series of 3-piperidinyl-5-sulfonylindazoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 19(12). 3214–3216. 9 indexed citations
10.
Liu, Kevin G., et al.. (2009). One-pot synthesis of highly substituted indolines. Tetrahedron. 66(3). 573–577. 28 indexed citations
11.
Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2009). 1-Sulfonylindazoles as potent and selective 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 19(9). 2413–2415. 17 indexed citations
12.
Liu, Kevin G. & Albert J. Robichaud. (2009). 5‐HT6 antagonists as potential treatment for cognitive dysfunction. Drug Development Research. 70(2). 145–168. 65 indexed citations
13.
Liu, Kevin G., Thomas A. Comery, Dianne Kowal, et al.. (2008). A regiospecific synthesis of a series of 1-sulfonyl azepinoindoles as potent 5-HT6 ligands. Bioorganic & Medicinal Chemistry Letters. 18(14). 3929–3931. 24 indexed citations
14.
Liu, Kevin G. & Albert J. Robichaud. (2006). Synthesis of 3,3-disubstituted oxindoles. Tetrahedron Letters. 48(3). 461–463. 28 indexed citations
15.
Liu, Kevin G., et al.. (2006). Rearrangement of 3,3-Disubstituted Indolenines and Synthesis of 2,3-Substituted Indoles. Organic Letters. 8(25). 5769–5771. 69 indexed citations
16.
Liu, Kevin G. & Albert J. Robichaud. (2006). A General and Convenient Synthesis of N‐Aryl Piperazines.. ChemInform. 37(7). 2 indexed citations
17.
Liu, Kevin G. & Albert J. Robichaud. (2005). A general and convenient synthesis of N-aryl piperazines. Tetrahedron Letters. 46(46). 7921–7922. 56 indexed citations
18.
Liu, Kevin G., Millard H. Lambert, Lisa M. Leesnitzer, et al.. (2001). Identification of a series of PPARγ/δ dual agonists via solid-Phase parallel synthesis. Bioorganic & Medicinal Chemistry Letters. 11(22). 2959–2962. 31 indexed citations
19.
Liu, Kevin G., Jennifer S. Smith, Brad R. Henke, et al.. (2001). Identification of a series of oxadiazole-substituted α-isopropoxy phenylpropanoic acids with activity on PPARα, PPARγ, and PPARδ. Bioorganic & Medicinal Chemistry Letters. 11(17). 2385–2388. 29 indexed citations
20.
Liu, Kevin G., Millard H. Lambert, Brad R. Henke, et al.. (2001). Synthesis and biological activity of l-tyrosine-based PPARγ agonists with reduced molecular weight. Bioorganic & Medicinal Chemistry Letters. 11(24). 3111–3113. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. E. Layton Breakdown of academic impact, for papers by Gisella Terre’Blanche Breakdown of academic impact, for papers by Ivan Efremov Breakdown of academic impact, for papers by Mark A. Sanner Breakdown of academic impact, for papers by Grant Wishart Breakdown of academic impact, for papers by E. FERNANDEZ‐ALVAREZ Breakdown of academic impact, for papers by Suzanne R. Kesten Breakdown of academic impact, for papers by David J. Madar Breakdown of academic impact, for papers by Laura Iturrino Breakdown of academic impact, for papers by Paul J. Dransfield
Rankless by CCL
2026